TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01647802

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standing attempts with the Vertic'Easy Device
Description: Included patients had never used any of the three devices evaluated in this study. Therefore the patient will make two attempts at standing on each device to enable him/her to get used to the device at the first attempt. A video recording will be made from a camera positioned laterally. Only the results of the second attempt will be a kinematic analysis and will be used for analyzes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standing attempts with the Vertic'Easy Device
Description: Included patients had never used any of the three devices evaluated in this study. Therefore the patient will make two attempts at standing on each device to enable him/her to get used to the device at the first attempt. A video recording will be made from a camera positioned laterally. Only the results of the second attempt will be a kinematic analysis and will be used for analyzes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standing attempts with the Vertic'Easy Device
Description: Included patients had never used any of the three devices evaluated in this study. Therefore the patient will make two attempts at standing on each device to enable him/her to get used to the device at the first attempt. A video recording will be made from a camera positioned laterally. Only the results of the second attempt will be a kinematic analysis and will be used for analyzes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standing attempts with the Turner Device
Description: Included patients had never used any of the three devices evaluated in this study. Therefore the patient will make two attempts at standing on each device to enable him/her to get used to the device at the first attempt. A video recording will be made from a camera positioned laterally. Only the results of the second attempt will be a kinematic analysis and will be used for analyzes

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standing attempts with the Turner Device
Description: Included patients had never used any of the three devices evaluated in this study. Therefore the patient will make two attempts at standing on each device to enable him/her to get used to the device at the first attempt. A video recording will be made from a camera positioned laterally. Only the results of the second attempt will be a kinematic analysis and will be used for analyzes
Study: NCT01594619

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diltiazem XR
Description: Oral 240mg tablet
Study: NCT02366832

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 17g Galil Medical Ice Sphere cryoablation needle
Description: Under CT guidance, the corresponding nerve will be targeted with a 17g probe. Two freeze-thaw cycles will be undertaken. The probe will be removed and a final scan obtained.
Study: NCT02218333

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Milk
Description: 4 dl milk will be consumed daily with breakfast and supper for 12 weeks
Study: NCT02218333

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT01863329

Intervention type: PROCEDURE
Intervention: retrobulbar ultrasound
Description: both optic nerve sheath diameter (the posterior 3mm of the papilla), 5 individual measurement
Study: NCT01647802

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standing attempts with the Turner Device
Description: Included patients had never used any of the three devices evaluated in this study. Therefore the patient will make two attempts at standing on each device to enable him/her to get used to the device at the first attempt. A video recording will be made from a camera positioned laterally. Only the results of the second attempt will be a kinematic analysis and will be used for analyzes

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standing attempts with the Turner Device
Description: Included patients had never used any of the three devices evaluated in this study. Therefore the patient will make two attempts at standing on each device to enable him/her to get used to the device at the first attempt. A video recording will be made from a camera positioned laterally. Only the results of the second attempt will be a kinematic analysis and will be used for analyzes
Study: NCT02755220

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cingularbio® Aortic valve replacement
Description: the patients will be replaced by Cingularbio heart valve
Study: NCT03910088

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pregabalin 100Mg Oral Cap
Description: giving a drug to relieve post-dural puncture headache

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydrocortisone
Description: Giving drug to relieve post-dural puncture headache

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen
Description: giving a drug to relieve post-dural puncture headache

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen
Description: giving a drug to relieve post-dural puncture headache

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Acetaminophen
Description: giving a drug to relieve post-dural puncture headache

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: oral fluids
Description: giving oral fluids to maintain good hydration

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: oral fluids
Description: giving oral fluids to maintain good hydration

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: oral fluids
Description: giving oral fluids to maintain good hydration

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Caffeine
Description: giving a drug to relieve post-dural puncture headache

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Caffeine
Description: giving a drug to relieve post-dural puncture headache

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Caffeine
Description: giving a drug to relieve post-dural puncture headache

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diclofenac
Description: giving a drug to relieve post-dural puncture headache

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diclofenac
Description: giving a drug to relieve post-dural puncture headache

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Diclofenac
Description: giving a drug to relieve post-dural puncture headache
Study: NCT04679974

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Melodic-based Communication Therapy
Description: General procedures involved in (M.B.C.T.) are as follows: 25 common first words are selected as the targets (e.g., apple, ball, car, dog, cat, eat, go, etc.). Pictures and objects will be used as stimulus items. The top 3-5 incentives as identified by parent survey will be given according to the therapies specific reinforcement schedule. All treatment and evaluation sessions will be videotaped for future/further analysis and verification purposes. For the purposes of the study design, the same 25 words will be used for all participants.~Participants will first listen to the target word set to a melodic tone and rhythm on a compact disc (CD). Clinicians will present the stimulus item (e.g., apple) prior to beginning the steps. Therapy will then progress from clapping and singing the melody to answering sung questions and finally to answering spoken questions with the target word
Study: NCT02155920

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Everolimus
Description: The recommended dose of Everolimus is 4.5 mg/m2/dose, once daily for up to 2 years, until disease progression or unacceptable toxicity occurs.
Study: NCT01647802

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standing attempts with the Tina device
Description: Included patients had never used any of the three devices evaluated in this study. Therefore the patient will make two attempts at standing on each device to enable him/her to get used to the device at the first attempt. A video recording will be made from a camera positioned laterally. Only the results of the second attempt will be a kinematic analysis and will be used for analyzes

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standing attempts with the Tina device
Description: Included patients had never used any of the three devices evaluated in this study. Therefore the patient will make two attempts at standing on each device to enable him/her to get used to the device at the first attempt. A video recording will be made from a camera positioned laterally. Only the results of the second attempt will be a kinematic analysis and will be used for analyzes

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standing attempts with the Tina device
Description: Included patients had never used any of the three devices evaluated in this study. Therefore the patient will make two attempts at standing on each device to enable him/her to get used to the device at the first attempt. A video recording will be made from a camera positioned laterally. Only the results of the second attempt will be a kinematic analysis and will be used for analyzes

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standing attempts with the Tina device
Description: Included patients had never used any of the three devices evaluated in this study. Therefore the patient will make two attempts at standing on each device to enable him/her to get used to the device at the first attempt. A video recording will be made from a camera positioned laterally. Only the results of the second attempt will be a kinematic analysis and will be used for analyzes

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standing attempts with the Tina device
Description: Included patients had never used any of the three devices evaluated in this study. Therefore the patient will make two attempts at standing on each device to enable him/her to get used to the device at the first attempt. A video recording will be made from a camera positioned laterally. Only the results of the second attempt will be a kinematic analysis and will be used for analyzes

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standing attempts with the Tina device
Description: Included patients had never used any of the three devices evaluated in this study. Therefore the patient will make two attempts at standing on each device to enable him/her to get used to the device at the first attempt. A video recording will be made from a camera positioned laterally. Only the results of the second attempt will be a kinematic analysis and will be used for analyzes
Study: NCT03226925

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Non-invasive mechanically-assisted ventilation
Description: Mechanically ventilation will be done through facial masks connected to a respirator. Volunteers/patients are fully conscious during the ventilation.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Non-invasive mechanically-assisted ventilation
Description: Mechanically ventilation will be done through facial masks connected to a respirator. Volunteers/patients are fully conscious during the ventilation.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Non-invasive mechanically-assisted ventilation
Description: Mechanically ventilation will be done through facial masks connected to a respirator. Volunteers/patients are fully conscious during the ventilation.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Dynamic MRI acquisition
Description: Dynamic MRI acquisition are specific dynamic sequences intended to visualise the motion of internal structures (anatomical structures or tumour) under non-invasive mechanically-assisted ventilation

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Dynamic MRI acquisition
Description: Dynamic MRI acquisition are specific dynamic sequences intended to visualise the motion of internal structures (anatomical structures or tumour) under non-invasive mechanically-assisted ventilation

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Planning 4D-CT
Description: In order to perform in-silico planning, 4D-CT will be acquired on patients under non-invasive mechanically-assisted ventilation
Study: NCT02564978

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minocycline
Description: Adult participants will be instructed to take their prescribed IP orally two times a day, once in the morning and once in the evening, approximately 12 hours apart. The capsules will be dispensed to the participant in a tight, light-resistant container as defined in the USP in three-month supply aliquots. Starting at Month 9 and continuing at Month 12, a three-month supply will be dispensed to the participant during the study visit or mailed to the participant. Participants will be given an instruction sheet for taking the prescribed IP. Starting at Month 15 participants will receive two bottles for a six-month supply. The IP should be stored between 15-30 degrees C (or 59-86 degrees F).They should be protected from light, moisture, and excessive heat. Participants will be required to bring their bottles of IP to each appropriate visit for capsule counts for compliance monitoring.
Study: NCT04289792

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nab-Paclitaxel+Gemcitabine
Description: Drug: nab-Paclitaxel 125 mg/m2 IV over approximately 30-45 min on Days 1 and 15, followed by gemcitabine 1000 mg/m2 IV infusion over approximately 30 min on Days 1 and 15 of each 28-day cycle for 6 cycles.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: split-course SBRT
Description: Radiation: During the first 1 and 2 cycles of chemotherapy, SBRT was given as a single irradiation of 10 Gy ⅹ 4 times (Days 2 and 16 of each 28-day cycle).
Study: NCT03658733

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: esomeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)
Description: Patients will go through a gastroscopy and antimicrobial susceptibility test. Liver and kidney function will be monitored by blood test before and after the treatment. Then, patients will receive a 14-day modified sequential therapy containing esomeprazole for the Helicobacter pylori eradication. The regimen contains a double dose esomeprazole, amoxicillin, tetracycline and furazolidone for the first 7 days, followed by esomeprazole, amoxicillin , tetracycline and colloidal bismuth pectin for the second 7 days.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)
Description: Patients will go through a gastroscopy and antimicrobial susceptibility test. Liver and kidney function will be monitored by blood test before and after the treatment. Then, patients will receive a 14-day modified sequential therapy containing rabeprazole for the Helicobacter pylori eradication. The regimen contains a double-dose rabeprazole, amoxicillin, tetracycline and furazolidone for the first 7 days, followed by rabeprazole, amoxicillin , tetracycline and colloidal bismuth pectin for the second 7 days.
Study: NCT03703089

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Administered by intravenous infusion over 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nab-paclitaxel
Description: Administered by intravenous infusion over 30-40 minutes.
Study: NCT05276921

Intervention type: OTHER
Intervention: ultrasound
Description: Quadriceps and abdominal muscle ultrasonography
Study: NCT00955396

Intervention type: DRUG
Group type: OTHER
Intervention: GSK1014802
Description: Tablets

Intervention type: DRUG
Group type: OTHER
Intervention: GSK1014802
Description: Tablets
Study: NCT00561678

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Precedex (Dexmedetomidine)
Description: 0.5/ug/kg/hr Dexmedetomidine infusions will begin prior to the surgery (no loading dose), and will be maintained at 0.5 mcg/kg/hour throughout surgery and titrated postoperatively for 2 hours postoperatively.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.5/ug/kg/hr Placebo infusions will begin prior to the surgery (no loading dose), and will be maintained at 0.5 mcg/kg/hour throughout surgery and titrated postoperatively for 2 hours postoperatively.
Study: NCT03228004

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Glooko MeterSync
Description: The participant and caregiver will receive a reminder via text or email to upload glucose data via Glooko on a biweekly basis.
Study: NCT03367312

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperpolarized 129Xenon gas
Description: Hyperpolarized 129Xenon gas XeMRI scans will provide 3D images of ventilation and gas exchange pre, post, and 2-4 hours post inhaled prostacyclin treatment. Subjects will inhale HP 129Xe from the dose delivery bags with each scan and then move into the scanner and undergo basic 1H localizer and anatomical scans. Once localization is complete, subjects will undergo several MRI scans after inhalation of HPXe. This will occur as three scans at the three different time points (pre, post, and 2-4 hours post) of inhaled prostacyclin treatment.
Study: NCT05340842

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: simulation training group
Description: In this study, applied breastfeeding training with Lactation Simulation Model was given to pregnant women in the intervention group (simulation training group, n=64) during antenatal period
Study: NCT00955396

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: Tablets

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: Tablets
Study: NCT02362165

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: 500mg/d,once-weekly,per oral.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: 1.3mg/㎡,once-weekly,subcutaneous injection

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bortezomib
Description: 1.3mg/㎡,once-weekly,subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: 40mg/d,once-weekly,per oral

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: 40mg/d,once-weekly,per oral

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Doxorubicin
Description: 9mg/㎡,d1-4
Study: NCT02489175

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stomaplasty KoringTM
Description: In these patients, the stomaplasty Koring will be implanted at the time of the primary definitive stoma creation. The implantation of the Koring will be performed by experienced surgeons (expertise based, best team approach) who have already implanted the Koring (e.g. participated in the observational study) and/or have reviewed the video documentation. To ensure standardization for all participating centres an operative manual with standardized video sequences is available.
Study: NCT02353091

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Remote Microphone Hearing Aids
Description: The ear receivers connect wirelessly with the microphone being worn by the teacher within a range of 25m.
Study: NCT04028011

Intervention type: DIAGNOSTIC_TEST
Intervention: Novel Wearable device
Description: patient will wear novel wearable device overnight along with normal standard of care

Intervention type: DIAGNOSTIC_TEST
Intervention: Novel Wearable device
Description: patient will wear novel wearable device overnight along with normal standard of care
Study: NCT00364780

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XL647
Description: XL647 will be administered orally as a single agent. XL647 will be supplied as 50 mg tablets. Subjects in the Intermittent 5 \& 9 cohort will receive XL647 at a dose of 350 mg on a 5 days on and 9 days off cycle every 2 weeks for 8 weeks. Subjects in the Daily Dosing cohort will receive XL647 administered daily as a single oral dose of 300 mg. In the absence of progressive disease (PD) and unacceptable XL647-related toxicity, subjects may continue to receive XL647 treatment on their assigned dosing schedule for up to 1 year on this study. Subjects who reach 1 year of treatment with no evidence of disease progression may, with the concurrence of the investigator and the sponsor, continue to receive therapy.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XL647
Description: XL647 will be administered orally as a single agent. XL647 will be supplied as 50 mg tablets. Subjects in the Intermittent 5 \& 9 cohort will receive XL647 at a dose of 350 mg on a 5 days on and 9 days off cycle every 2 weeks for 8 weeks. Subjects in the Daily Dosing cohort will receive XL647 administered daily as a single oral dose of 300 mg. In the absence of progressive disease (PD) and unacceptable XL647-related toxicity, subjects may continue to receive XL647 treatment on their assigned dosing schedule for up to 1 year on this study. Subjects who reach 1 year of treatment with no evidence of disease progression may, with the concurrence of the investigator and the sponsor, continue to receive therapy.
Study: NCT04007172

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: neural therapy
Description: Intracutaneous quaddle injections were performed using 1% lidocaine preparation as a local anesthetic for local application to painful points with palpation on the back and shoulders and for the segmental application, 2 cm lateral to the midline of the C1-T5 vertebrae and on spinous processes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Physical Therapy
Description: Physical therapy program was consist of transcutaneous electrical nerve stimulation- TENS (30-40 Hz, 20 minutes), hotpack (20 minutes) and continuous ultrasound (1mHz, 1.5w / cm2, 10 minutes) on painful points with palpation on the back and shoulders.